Teleflex Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Teleflex ha aumentado sus beneficios a una tasa media anual de 4.7%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 13.5% anual. Los ingresos han ido creciendo a una tasa media de 3.8% al año. La rentabilidad financiera de Teleflex es de 8.1%, y sus márgenes netos son de 12%.

Información clave

0.7%

Tasa de crecimiento de los beneficios

0.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	8.9%
Tasa de crecimiento de los ingresos	3.9%
Rentabilidad financiera	6.6%
Margen neto	9.9%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Feb 19

Is Teleflex (NYSE:TFX) A Risky Investment?

Feb 02

Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult

Jan 17

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Dec 31

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Nov 13

We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt

Oct 29

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Oct 13

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Oct 13

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Sep 27

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Aug 07

Teleflex: Flexing Its Muscles A Bit

Jul 27

Is Teleflex (NYSE:TFX) A Risky Investment?

Jul 20

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Jul 05

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

Jun 22

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Jun 20

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

May 05

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Apr 17

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Mar 31

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Mar 14

Teleflex's 2 catheter devices get FDA clearance

Feb 22

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Jan 27

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Jan 12

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Jan 11

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

Dec 28

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Dec 12

Teleflex recalls over 2.7M bacterial filters – FDA

Nov 01

Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy

Oct 25

Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)

Oct 17

Is Teleflex (NYSE:TFX) Using Too Much Debt?

Oct 03

Is Teleflex Incorporated (NYSE:TFX) Trading At A 44% Discount?

Sep 05

Teleflex to acquire Standard Bariatrics for $170M

Aug 22

Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching

Aug 08

Telefex: Valuations Are Stretched, Lack Of Risk Premia To Harvest

Jul 25

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

Jul 12

Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate

Jul 01

Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?

Jun 27

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Teleflex. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:TFX Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	3,001	296	1,141	150
31 Dec 23	2,974	358	991	154
01 Oct 23	2,959	405	925	161
02 Jul 23	2,899	369	904	161
02 Apr 23	2,860	363	888	159
31 Dec 22	2,791	363	861	154
25 Sep 22	2,795	412	862	147
26 Jun 22	2,808	510	856	141
27 Mar 22	2,817	488	859	137
31 Dec 21	2,810	485	852	131
26 Sep 21	2,759	434	836	129
27 Jun 21	2,687	351	829	126
28 Mar 21	2,540	280	784	122
31 Dec 20	2,537	336	782	120
27 Sep 20	2,507	367	772	117
28 Jun 20	2,527	479	770	116
29 Mar 20	2,612	551	798	114
31 Dec 19	2,595	462	798	114
29 Sep 19	2,556	442	804	111
30 Jun 19	2,517	269	812	109
31 Mar 19	2,475	183	814	107
31 Dec 18	2,448	196	744	106
30 Sep 18	2,402	66	822	104
01 Jul 18	2,327	89	784	99
01 Apr 18	2,246	170	738	93
31 Dec 17	2,146	155	696	85
01 Oct 17	2,065	259	634	75
02 Jul 17	1,986	246	611	69
02 Apr 17	1,931	227	594	64
31 Dec 16	1,868	237	570	59
25 Sep 16	1,828	267	569	56
26 Jun 16	1,816	262	569	54
27 Mar 16	1,795	248	568	52
31 Dec 15	1,799	236	574	52
27 Sep 15	1,798	197	578	56
28 Jun 15	1,808	191	577	58
29 Mar 15	1,821	194	586	60
31 Dec 14	1,827	190	586	61
28 Sep 14	1,802	174	573	62
29 Jun 14	1,759	164	554	62
30 Mar 14	1,711	159	526	64
31 Dec 13	1,685	151	502	65
29 Sep 13	1,656	147	493	63
30 Jun 13	1,613	125	488	63

Ingresos de calidad: TFX tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(12%) de TFX son inferiores a los del año pasado (13%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de TFX han crecido un 4.7% al año en los últimos 5 años.

Acelerando crecimiento: TFX ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: TFX tuvo un crecimiento negativo de los beneficios (-1.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (3.3%).

Teleflex Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: EPS misses analyst expectations

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: EPS misses analyst expectations

Recent updates

Teleflex Incorporated Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray

First quarter dividend of US$0.34 announced

Teleflex Incorporated Announces Quarterly Cash Dividend, Payable on June 14, 2024

Teleflex: Compelling, Despite Some Operational Hiccups

Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Fourth quarter dividend of US$0.34 announced

Full year 2023 earnings: EPS misses analyst expectations

Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Is Teleflex (NYSE:TFX) A Risky Investment?

Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult

Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Chairman notifies of intention to sell stock

Executive VP & CFO exercised options and sold US$1.4m worth of stock

Teleflex Incorporated Announces First Patient Enrollment in ACCESS-MANTA Registry

Teleflex Incorporated Announces A New Peer-Reviewed Study in the Nature Journal Prostate Cancer and Prostatic Diseases Confirms the Position of the UroLift System as the Gold Standard in Minimally Invasive Surgical Treatment

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Teleflex Incorporated Announces Extension of Arrow ErgoPack Complete System to Hemodialysis and Large Bore Central Venous Catheters

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Upcoming dividend of US$0.34 per share at 0.6% yield

Teleflex Incorporated Updates Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Teleflex Incorporated Receives FDA Clearance for Expanded Indication for QuikClot Control+(TM) Hemostatic Device Usage in Cardiac Surgical Procedures

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB for $650 million.

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB from Östersjöstiftelsen, Endowment Arm, Praktikerinvest AB and Recipharm Venture Fund AB for $650 million.

Teleflex: Flexing Its Muscles A Bit

Is Teleflex (NYSE:TFX) A Risky Investment?

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Teleflex Incorporated Receives FDA Clearance for the Wattson Temporary Pacing Guidewire

Teleflex Incorporated Announces the Arrow(R) EZ-Io(R) Needle Is Now FDA Cleared for Use in an MRI Environment

Independent Director notifies of intention to sell stock

Teleflex Announces Quarterly Dividend, June 15, 2023

Teleflex Incorporated Provides Earnings Guidance for the Year 2023

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Full year 2022 earnings: EPS misses analyst expectations

Teleflex's 2 catheter devices get FDA clearance

Independent Director exercised options and sold US$161k worth of stock

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Chairman exercised options and sold US$1.0m worth of stock

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Chairman notifies of intention to sell stock

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Price target decreased to US$248

Insufficient new directors

Upcoming dividend of US$0.34 per share

Teleflex Incorporated Announces Worldwide Recall of Affected Lots of Gibeck Iso-Gard Filter Products

Teleflex recalls over 2.7M bacterial filters – FDA

Desglose de ingresos y gastos
Beta